Detalhe da pesquisa
1.
A phase II trial with anti-Lewis-Y monoclonal antibody (hu3S193) for the treatment of platinum resistant/refractory ovarian, fallopian tube and primary peritoneal carcinoma.
Gynecol Oncol
; 138(2): 272-7, 2015 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-26026738
2.
Phase I trial of erlotinib combined with cisplatin and radiotherapy for patients with locally advanced cervical squamous cell cancer.
Clin Cancer Res
; 14(19): 6324-9, 2008 Oct 01.
Artigo
Inglês
| MEDLINE | ID: mdl-18829516